Title:
【発明の名称】Gタンパク質結合受容体
Document Type and Number:
Japanese Patent JP2003528633
Kind Code:
A
Abstract:
The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.
Inventors:
Jennifer Elle, Polky
Tribole, Katharine M
Tongue, Tom Wye
Bogun, Mariah Earl
Grall, Richard
Khan, Fara Aye
Naen, Daniel Bee
Patterson, Chandra
Ral, Pretty
Ou-Young, Janis El
Young, Junming
Hafalia, april
Straw, Nalinder Kay
Das, Devopriva
Tribole, Katharine M
Tongue, Tom Wye
Bogun, Mariah Earl
Grall, Richard
Khan, Fara Aye
Naen, Daniel Bee
Patterson, Chandra
Ral, Pretty
Ou-Young, Janis El
Young, Junming
Hafalia, april
Straw, Nalinder Kay
Das, Devopriva
Application Number:
JP2001571767A
Publication Date:
September 30, 2003
Filing Date:
March 29, 2001
Export Citation:
Assignee:
Insight Genomics Incorporated
International Classes:
A61K38/00; A61K45/00; A61P1/04; A61P1/12; A61P1/14; A61P1/16; A61P1/18; A61P3/04; A61P3/10; A61P5/14; A61P7/00; A61P7/02; A61P7/04; A61P7/06; A61P9/00; A61P9/04; A61P9/10; A61P9/12; A61P11/00; A61P11/06; A61P13/12; A61P17/02; A61P17/06; A61P19/02; A61P19/06; A61P19/10; A61P21/00; A61P21/04; A61P25/02; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/28; A61P27/02; A61P29/00; A61P31/04; A61P31/10; A61P31/12; A61P35/00; A61P35/02; A61P37/02; A61P37/08; A61P43/00; C07K14/705; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12N15/09; C12N15/12; C12P21/02; C12P21/08; C12Q1/02; C12Q1/68; C12S3/14; G01N33/15; G01N33/53; G01N33/566; G01N33/50; (IPC1-7): C12N15/09; A61K38/00; A61K45/00; A61P1/04; A61P1/12; A61P1/14; A61P1/16; A61P1/18; A61P3/04; A61P3/10; A61P5/14; A61P7/00; A61P7/02; A61P7/04; A61P7/06; A61P9/00; A61P9/04; A61P9/10; A61P9/12; A61P11/00; A61P11/06; A61P13/12; A61P17/02; A61P17/06; A61P19/02; A61P19/06; A61P19/10; A61P21/00; A61P21/04; A61P25/02; A61P25/08; A61P25/14; A61P25/16; A61P25/18; A61P25/20; A61P25/22; A61P25/28; A61P27/02; A61P29/00; A61P31/04; A61P31/10; A61P31/12; A61P35/00; A61P35/02; A61P37/02; A61P37/08; A61P43/00; C07K14/705; C07K16/28; C12N1/15; C12N1/19; C12N1/21; C12N5/10; C12P21/02; C12P21/08; C12Q1/02; C12Q1/68; C12S3/14; G01N33/15; G01N33/50; G01N33/53; G01N33/566
Attorney, Agent or Firm:
Youichi Oshima
Previous Patent: 血管内皮成長因子（ＶＥＧＦ）−媒介性脈管形成を阻害するペプチド、該...
Next Patent: 単離ヒトＧタンパク質共役受容体、ヒトＧＰＣＲタンパク質をコード化し...
Next Patent: 単離ヒトＧタンパク質共役受容体、ヒトＧＰＣＲタンパク質をコード化し...